{"slideshow_credits": null, "snippet": "Many of the documents, newly unsealed by a court, centered on whether research would undercut a selling point: that the blood-thinning drug, Pradaxa, does not require regular tests.", "abstract": "Documents released by FederalJudge David R Herndon say Boehringer Ingelheim, maker of blood-thinning drug Pradaxa, was so worried that internal research paper would damage drug sales that some employees not only pressured author to revise it, but suggested it should be quashed altogether; company has stood by drug.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}], "original": "By KATIE THOMAS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/02/06/business/study-of-blood-clot-drug-pradaxa-unnerved-its-maker-documents-suggest.html", "lead_paragraph": "Many of the documents, newly unsealed by a court, centered on whether research would undercut a selling point: that the blood-thinning drug, Pradaxa, does not require regular tests.", "headline": {"main": "Study of Drug for Blood Clots Caused a Stir, Records Show", "print_headline": "Study of Drug for Blood Clots Caused a Stir, Records Show"}, "_id": "52f2ab3038f0d814439d918a", "word_count": "1277", "multimedia": [{"height": 126, "url": "images/2014/02/06/business/Blood/Blood-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/02/06/business/Blood/Blood-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 749, "url": "images/2014/02/06/business/Blood/Blood-articleLarge.jpg", "legacy": {"xlarge": "images/2014/02/06/business/Blood/Blood-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "749"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/02/06/business/Blood/Blood-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/02/06/business/Blood/Blood-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-02-06T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Research", "name": "subject", "is_major": "N", "rank": "5"}, {"value": "Blood Clots", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Pradaxa (Drug)", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Boehringer Ingelheim GmbH", "name": "organizations", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}